ARROWHEAD PHARMACEUTICALS IN (ARWR)
US04280A1007 - Common Stock
ChartMill assigns a Buy % Consensus number of 79% to ARWR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 56.49. This target is 131.15% above the current price.
ARWR was analyzed by 20 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about ARWR.
In the previous month the buy percentage consensus was at a similar level.
ARWR was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-07 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-07 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-01-16 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-01-02 | B of A Securities | Maintains | Buy -> Buy |
| 2023-12-04 | B of A Securities | Initiate | Buy |
| 2023-11-30 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-11-30 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-19 | Citigroup | Initiate | Neutral |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-08 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-08-08 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-07-21 | TD Cowen | Initiate | Outperform |
| 2023-07-20 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2023-06-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-02 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-06-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-05-24 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-05-12 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2023-05-03 | RBC Capital | Reiterate | Outperform |
| 2023-05-03 | Goldman Sachs | Maintains | Buy |
| 2023-05-03 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-04-26 | SMBC Nikko | Initiate | Outperform |
| 2023-04-12 | SVB Securities | Upgrade | Market Perform -> Outperform |
| 2023-03-21 | Bernstein | Initiate | Market Perform |
| 2023-02-10 | Chardan Capital | Reiterate | Buy |
| 2023-02-10 | HC Wainwright & Co. | Reiterate | Buy |